BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17015495)

  • 1. Pharmacokinetics of pyridostigmine in a child with postural tachycardia syndrome.
    Filler G; Gow RM; Nadarajah R; Jacob P; Johnson G; Zhang YL; Christians U
    Pediatrics; 2006 Nov; 118(5):e1563-8. PubMed ID: 17015495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience.
    Kanjwal K; Karabin B; Sheikh M; Elmer L; Kanjwal Y; Saeed B; Grubb BP
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):750-5. PubMed ID: 21410722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyridostigmine in the treatment of postural orthostatic tachycardia syndrome].
    Can I; Tholakanahalli V
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):553-5. PubMed ID: 25362946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome.
    Raj SR; Black BK; Biaggioni I; Harris PA; Robertson D
    Circulation; 2005 May; 111(21):2734-40. PubMed ID: 15911704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the cardiologist in the evaluation of dysautonomia.
    Boris JR
    Cardiol Young; 2010 Dec; 20 Suppl 3():135-9. PubMed ID: 21087570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pyridostigmine in the treatment of primary orthostatic hypotension].
    Monge Argiles JA; Leiva Santana C
    Neurologia; 2007 May; 22(4):260-2. PubMed ID: 17492522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase inhibition in patients with orthostatic intolerance.
    Singer W; Opfer-Gehrking TL; Nickander KK; Hines SM; Low PA
    J Clin Neurophysiol; 2006 Oct; 23(5):476-81. PubMed ID: 17016160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postural orthostatic tachycardia syndrome: anesthetic implications in the obstetric patient.
    McEvoy MD; Low PA; Hebbar L
    Anesth Analg; 2007 Jan; 104(1):166-7. PubMed ID: 17179264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural orthostatic tachycardia syndrome: an underrecognized disorder.
    Pandian JD; Dalton K; Henderson RD; McCombe PA
    Intern Med J; 2007 Aug; 37(8):529-35. PubMed ID: 17445012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of pediatric ocular myasthenia gravis.
    Ortiz S; Borchert M
    Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain.
    Amourette C; Lamproglou I; Barbier L; Fauquette W; Zoppe A; Viret R; Diserbo M
    Behav Brain Res; 2009 Nov; 203(2):207-14. PubMed ID: 19433115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postural orthostatic tachycardia syndrome: a clinical review.
    Johnson JN; Mack KJ; Kuntz NL; Brands CK; Porter CJ; Fischer PR
    Pediatr Neurol; 2010 Feb; 42(2):77-85. PubMed ID: 20117742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supine Parasympathetic Withdrawal and Upright Sympathetic Activation Underly Abnormalities of the Baroreflex in Postural Tachycardia Syndrome: Effects of Pyridostigmine and Digoxin.
    Stewart JM; Warsy IA; Visintainer P; Terilli C; Medow MS
    Hypertension; 2021 Apr; 77(4):1234-1244. PubMed ID: 33423527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The simultaneous monitoring of plasma levels of neostigmine and pyridostigmine in man.
    Davison SC; Hyman N; Prentis RA; Dehghan A; Chan K
    Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):77-82. PubMed ID: 7339332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
    Moon J; Kim DY; Lee WJ; Lee HS; Lim JA; Kim TJ; Jun JS; Park B; Byun JI; Sunwoo JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
    Neurotherapeutics; 2018 Jul; 15(3):785-795. PubMed ID: 29500811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging alters the pharmacokinetics of pyridostigmine.
    Stone JG; Matteo RS; Ornstein E; Schwartz AE; Ostapkovich N; Jamdar SC; Diaz J
    Anesth Analg; 1995 Oct; 81(4):773-6. PubMed ID: 7574009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans.
    Marino MT; Schuster BG; Brueckner RP; Lin E; Kaminskis A; Lasseter KC
    J Clin Pharmacol; 1998 Mar; 38(3):227-35. PubMed ID: 9549661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers.
    Lai CC; Fischer PR; Brands CK; Fisher JL; Porter CB; Driscoll SW; Graner KK
    Pacing Clin Electrophysiol; 2009 Feb; 32(2):234-8. PubMed ID: 19170913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular autonomic reflexes on the postural orthostatic tachycardia syndrome].
    Benjelloun H; Benjelloun H; Aboudrar S; Coghlan L; Benomar M
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):20-6. PubMed ID: 18656847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.